DK1411917T3 - Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser - Google Patents

Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser

Info

Publication number
DK1411917T3
DK1411917T3 DK02714978T DK02714978T DK1411917T3 DK 1411917 T3 DK1411917 T3 DK 1411917T3 DK 02714978 T DK02714978 T DK 02714978T DK 02714978 T DK02714978 T DK 02714978T DK 1411917 T3 DK1411917 T3 DK 1411917T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
movement disorders
carbamate compounds
carbamate
Prior art date
Application number
DK02714978T
Other languages
Danish (da)
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1411917T3 publication Critical patent/DK1411917T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02714978T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser DK1411917T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168301P 2001-02-27 2001-02-27
US10/081,501 US6589985B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating movement disorders
PCT/US2002/005542 WO2002067926A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating movement disorders

Publications (1)

Publication Number Publication Date
DK1411917T3 true DK1411917T3 (da) 2007-09-24

Family

ID=26765643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02714978T DK1411917T3 (da) 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser

Country Status (27)

Country Link
US (1) US6589985B2 (https=)
EP (1) EP1411917B1 (https=)
JP (1) JP2004527492A (https=)
KR (1) KR100858232B1 (https=)
CN (1) CN1262272C (https=)
AR (1) AR033426A1 (https=)
AT (1) ATE369130T1 (https=)
AU (1) AU2002247204B2 (https=)
BR (1) BR0207831A (https=)
CA (1) CA2439478C (https=)
CY (1) CY1106924T1 (https=)
CZ (1) CZ20032299A3 (https=)
DE (1) DE60221670T2 (https=)
DK (1) DK1411917T3 (https=)
ES (1) ES2291454T3 (https=)
HU (1) HUP0303344A3 (https=)
IL (2) IL157592A0 (https=)
MX (1) MXPA03007719A (https=)
MY (1) MY157373A (https=)
NO (1) NO20033803L (https=)
NZ (1) NZ551954A (https=)
PL (1) PL364679A1 (https=)
PT (1) PT1411917E (https=)
RS (1) RS50676B (https=)
RU (1) RU2294739C2 (https=)
TW (1) TWI331524B (https=)
WO (1) WO2002067926A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
PL364680A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368164A1 (en) 2001-07-16 2005-03-21 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ES2435403T3 (es) 2005-06-08 2013-12-19 Sk Biopharmaceuticals Co., Ltd. Tratamiento de trastornos del sueño y vigilia
PE20070325A1 (es) * 2005-06-29 2007-05-12 Alza Corp Formas de dosificacion oral que comprenden compuestos derivados de carbamato
AU2005335241B9 (en) * 2005-07-26 2012-12-20 Sk Biopharmaceuticals Co., Ltd. Methods for treating substance-related disorders
MX2009004798A (es) * 2006-10-31 2009-08-12 Janssen Pharmaceutica Nv Tratamiento de los trastornos generalizados del desarrollo.
MX350745B (es) 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (en) * 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
ES3059582T3 (en) 2016-02-29 2026-03-23 Bio Pharm Solutions Co Ltd Sulfamate derivative compounds, processes for preparing them and their uses
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
MX391363B (es) * 2016-12-14 2025-03-21 Sk Biopharmaceuticals Co Ltd Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.
AU2018278332B2 (en) 2017-06-02 2022-05-19 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
JP2023539291A (ja) * 2020-08-31 2023-09-13 バイオ-ファーム ソリューションズ カンパニー リミテッド 神経変性疾患の予防又は治療用フェニルアルキルカルバメート化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
IL157592A (en) 2009-12-24
WO2002067926A1 (en) 2002-09-06
YU67703A (sh) 2006-08-17
AR033426A1 (es) 2003-12-17
HK1067305A1 (en) 2005-04-08
CN1262272C (zh) 2006-07-05
EP1411917B1 (en) 2007-08-08
KR100858232B1 (ko) 2008-09-12
NO20033803L (no) 2003-10-10
ES2291454T3 (es) 2008-03-01
BR0207831A (pt) 2004-06-22
RS50676B (sr) 2010-06-30
CY1106924T1 (el) 2012-09-26
PL364679A1 (en) 2004-12-13
IL157592A0 (en) 2004-03-28
KR20030074847A (ko) 2003-09-19
ATE369130T1 (de) 2007-08-15
US20020151585A1 (en) 2002-10-17
CA2439478C (en) 2010-05-18
NO20033803D0 (no) 2003-08-26
HUP0303344A3 (en) 2012-07-30
CN1505508A (zh) 2004-06-16
MXPA03007719A (es) 2004-11-12
PT1411917E (pt) 2007-09-17
HUP0303344A2 (hu) 2004-01-28
US6589985B2 (en) 2003-07-08
DE60221670T2 (de) 2008-04-30
EP1411917A1 (en) 2004-04-28
CZ20032299A3 (cs) 2004-08-18
CA2439478A1 (en) 2002-09-06
JP2004527492A (ja) 2004-09-09
DE60221670D1 (de) 2007-09-20
AU2002247204B2 (en) 2006-08-24
RU2294739C2 (ru) 2007-03-10
NZ551954A (en) 2008-07-31
TWI331524B (en) 2010-10-11
MY157373A (en) 2016-06-15
RU2003128985A (ru) 2005-03-10

Similar Documents

Publication Publication Date Title
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1446122T5 (da) Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK2412368T3 (da) Sammensætning til behandling af ar
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
DK1656372T3 (da) 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
DK1660057T3 (da) Kombinationsterapi til behandling af neovaskulære øjenlidelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1383489T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1694342T3 (da) Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DK1401424T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
ITMI20030274A1 (it) Elemento correttore per l'articolazione tra femore e bacino.